On Invalid Date, Edwards Lifesciences (NYSE: EW) reported Q3 2023 earnings per share (EPS) of $0.63, up 14.55% year over year. Total Edwards Lifesciences earnings for the quarter were $384.90 million. In the same quarter last year, Edwards Lifesciences's earnings per share (EPS) was $0.55.
As of Q4 2023, Edwards Lifesciences's earnings has grown 0.43% year over year. This is 17.67 percentage points lower than the US Medical Devices industry earnings growth rate of 18.1%. Edwards Lifesciences's earnings in the past year totalled $1.43 billion.
What is EW's earnings date?
Edwards Lifesciences's earnings date is Invalid Date. Add EW to your watchlist to be reminded of EW's next earnings announcement.
What was EW's revenue last quarter?
On Invalid Date, Edwards Lifesciences (NYSE: EW) reported Q3 2023 revenue of $1.48 billion up 12.27% year over year. In the same quarter last year, Edwards Lifesciences's revenue was $1.32 billion.
What was EW's revenue growth in the past year?
As of Q4 2023, Edwards Lifesciences's revenue has grown 8.49% year over year. This is 1.73 percentage points higher than the US Medical Devices industry revenue growth rate of 6.76%. Edwards Lifesciences's revenue in the past year totalled $5.82 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.